Complete Filing Data
Rani Therapeutics Holdings, Inc. reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $41.51 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Rani Therapeutics Holdings, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$29.7M | -$30.0M | -$34.0M | -$30.6M | -$8.3M | -$16.7M |
| Research And Development Expense | $20.2M | $26.7M | $39.6M | $36.6M | $26.5M | $12.0M |
| Operating Income Loss | -$38.3M | -$53.3M | -$66.1M | -$63.5M | -$51.6M | -$16.5M |
| Operating Expenses | $39.9M | $54.3M | $66.1M | $63.5M | $54.3M | -$17.0M |
| General And Administrative Expense | $19.7M | $23.9M | $26.5M | $26.8M | $27.8M | $5.0M |
| Interest Expense | $2.9M | $5.0M | $5.1M | $1.1M | $466.0K | $124.0K |
| Net Income Loss Attributable To Noncontrolling Interest | -$11.3M | -$26.6M | -$33.9M | -$32.8M | -$44.8M | -$16.7M |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$41.0M | -$56.6M | -$67.8M | -$63.5M | -$53.1M | |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$11.3M | -$26.6M | -$33.9M | -$32.8M | -$44.8M | |
| Comprehensive Income Net Of Tax | -$29.7M | -$30.0M | -$33.9M | -$30.7M | -$8.3M | |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | -$6.0K | $33.0K | $121.0K | -$149.0K | $0.00 | |
| Other Comprehensive Income Loss Net Of Tax | -$6.0K | $33.0K | $121.0K | -$149.0K | ||
| Revenue From Contract With Customer Excluding Assessed Tax | $1.6M | $1.0M | $0.00 | $0.00 | $2.7M | $462.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$67.9M | -$63.3M | -$53.0M | -$16.7M | ||
| Income Tax Expense Benefit | $0.00 | $70.0K | $41.0K | $35.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$5.4M | -$6.7M | -$7.3M | -$6.8M | -$6.8M | -$7.5M | -$9.2M | -$9.3M | -$8.4M | -$8.0M | -$7.6M | -$6.2M | -$3.1M | -$5.5M | -$5.6M | -$2.9M | -$2.7M | -$5.4M |
| Research And Development Expense | $3.2M | $5.5M | $6.6M | $6.2M | $6.1M | $7.6M | $11.2M | $11.1M | $9.7M | $9.1M | $9.5M | $7.6M | $12.0M | $3.8M | $3.3M | $2.1M | $2.6M | |
| Operating Income Loss | -$7.3M | -$10.5M | -$12.0M | -$11.8M | -$12.5M | -$14.0M | -$17.9M | -$18.3M | -$16.5M | -$16.3M | -$15.8M | -$13.8M | -$27.8M | -$5.3M | -$5.2M | -$2.8M | -$3.4M | |
| Operating Expenses | $7.3M | $10.5M | $12.2M | $11.8M | $12.5M | $14.0M | $17.9M | $18.3M | $16.5M | $16.3M | $15.8M | $13.8M | $27.8M | $7.2M | $6.0M | $2.9M | $3.5M | |
| General And Administrative Expense | $4.0M | $5.0M | $5.6M | $5.6M | $6.4M | $6.4M | $6.6M | $7.2M | $6.8M | $7.2M | $6.3M | $6.2M | $15.8M | $3.5M | $2.6M | $845.0K | $892.0K | |
| Interest Expense | $725.0K | $877.0K | $943.0K | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.2M | $352.0K | $0.00 | $0.00 | $110.0K | $169.0K | $188.0K | $64.0K | $2.0K | |
| Net Income Loss Attributable To Noncontrolling Interest | -$2.5M | -$4.5M | -$5.5M | -$5.9M | -$6.6M | -$7.3M | -$9.1M | -$9.4M | -$8.5M | -$8.3M | -$8.3M | -$7.6M | -$25.6M | -$5.5M | -$5.6M | -$2.9M | ||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$7.9M | -$11.2M | -$12.7M | -$12.7M | -$13.3M | -$14.8M | -$18.3M | -$18.8M | -$16.7M | -$16.3M | -$16.0M | -$13.8M | -$28.7M | |||||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$2.5M | -$4.2M | -$5.5M | -$5.9M | -$6.6M | -$7.3M | -$9.1M | -$9.4M | -$8.4M | -$8.3M | -$8.3M | -$7.6M | -$25.6M | |||||
| Comprehensive Income Net Of Tax | -$5.4M | -$7.0M | -$7.3M | -$6.8M | -$6.8M | -$7.5M | -$9.2M | -$9.4M | -$8.3M | -$8.0M | -$7.6M | -$6.2M | -$3.1M | |||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | $0.00 | $1.0K | -$6.0K | $24.0K | $12.0K | $1.0K | $45.0K | -$107.0K | $126.0K | -$118.0K | $0.00 | $0.00 | ||||||
| Other Comprehensive Income Loss Net Of Tax | $1.0K | -$6.0K | $24.0K | $12.0K | $1.0K | $45.0K | -$107.0K | $126.0K | -$118.0K | |||||||||
| Revenue From Contract With Customer Excluding Assessed Tax | $0.00 | $0.00 | $172.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2.0M | $756.0K | $108.0K | $60.0K | |||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$18.3M | -$18.7M | -$16.8M | -$16.3M | -$15.8M | -$13.8M | -$28.7M | -$5.5M | -$5.6M | -$2.9M | -$2.7M | |||||||
| Income Tax Expense Benefit | $0.00 | $0.00 | $107.0K | $154.0K | $63.0K | $37.0K | $1.0K | $43.0K | $5.0K | $6.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $33.0M | $2.0M | $12.9M | $36.9M | $47.4M | -$113.3M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $18.8M | $4.3M | $6.4M | $27.5M | $117.5M | $73.1M | |
| Cash And Cash Equivalents At Carrying Value | $18.6M | $3.8M | $5.9M | $27.0M | $117.5M | $73.1M | |
| Retained Earnings Accumulated Deficit | -$132.6M | -$102.9M | -$72.9M | -$38.9M | -$8.3M | -$114.0M | |
| Property Plant And Equipment Net | $736.0K | $1.5M | $6.1M | $6.0M | $4.6M | $4.5M | |
| Liabilities Current | $12.7M | $19.9M | $8.0M | $4.8M | $2.6M | $5.3M | |
| Liabilities And Stockholders Equity | $58.6M | $36.6M | $57.9M | $108.0M | $124.2M | $79.4M | |
| Liabilities | $17.1M | $33.1M | $32.5M | $34.0M | $2.6M | $8.0M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $14.6M | -$2.1M | -$21.1M | -$89.9M | $44.4M | $56.5M | |
| Assets Current | $53.3M | $29.7M | $50.8M | $100.9M | $119.6M | $74.9M | |
| Assets | $58.6M | $36.6M | $57.9M | $108.0M | $124.2M | $79.4M | |
| Accounts Payable Current | $309.0K | $1.4M | $648.0K | $1.5M | $1.1M | $537.0K | |
| Minority Interest | $8.5M | $1.5M | $12.6M | $37.1M | $74.2M | $0.00 | |
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Long Term Debt Noncurrent | $0.00 | $9.6M | $24.5M | $29.1M | $0.00 | $2.4M | |
| Operating Lease Right Of Use Asset Amortization Expense | $1.9M | $1.8M | $1.0M | $764.0K | $0.00 | ||
| Operating Lease Right Of Use Asset | $4.3M | $5.1M | $718.0K | $1.1M | $0.00 | ||
| Operating Lease Liability Noncurrent | $2.7M | $3.6M | $0.00 | $59.0K | $0.00 | ||
| Operating Lease Liability Current | $1.6M | $1.5M | $718.0K | $1.0M | $0.00 | ||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $0.00 | $4.7M | $0.00 | $514.0K | $0.00 | ||
| Marketable Securities | $31.1M | $23.9M | $42.7M | $71.5M | $0.00 | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $1.0K | $5.0K | -$12.0K | -$73.0K | $0.00 | ||
| Accretion Amortization Of Discounts And Premiums Investments | $278.0K | $1.2M | $2.3M | $851.0K | $0.00 | ||
| Long Term Debt Current | $0.00 | $15.0M | $4.9M | $0.00 | $1.4M | ||
| Accrued Liabilities And Other Liabilities | $3.9M | $2.1M | $1.7M | $2.3M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $16.5M | ||||||
| Other Operating Activities Cash Flow Statement | $0.00 | -$245.0K | $0.00 | $109.0K | $47.0K | ||
| Other Assets Noncurrent | $246.0K | $246.0K | $246.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | -$7.9M | -$5.6M | -$3.1M | $3.1M | $2.8M | $7.4M | $17.6M | $24.1M | $30.7M | $42.2M | $47.8M | $53.4M | $51.4M | -$123.7M | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $4.6M | $10.7M | $10.6M | $4.8M | $5.0M | $7.4M | $5.5M | $8.1M | $19.5M | $27.7M | $97.2M | $107.8M | $129.7M | ||||||
| Cash And Cash Equivalents At Carrying Value | $4.1M | $10.2M | $10.1M | $4.3M | $4.5M | $6.9M | $5.0M | $7.6M | $19.0M | $27.2M | $97.2M | $107.8M | $129.7M | $69.3M | |||||
| Retained Earnings Accumulated Deficit | -$122.3M | -$116.9M | -$110.2M | -$94.0M | -$87.2M | -$80.4M | -$65.8M | -$56.6M | -$47.3M | -$30.1M | -$22.2M | -$14.6M | -$3.1M | -$125.1M | |||||
| Property Plant And Equipment Net | $922.0K | $1.1M | $1.3M | $5.5M | $5.7M | $5.9M | $6.3M | $5.9M | $6.0M | $5.7M | $5.4M | $4.9M | $4.6M | $4.4M | |||||
| Liabilities Current | $19.1M | $20.6M | $20.1M | $20.2M | $16.6M | $13.4M | $7.3M | $5.7M | $5.2M | $7.2M | $5.3M | $4.2M | $5.3M | $9.4M | |||||
| Liabilities And Stockholders Equity | $10.1M | $16.9M | $24.1M | $43.5M | $43.7M | $53.5M | $70.4M | $83.5M | $96.4M | $108.2M | $104.3M | $115.3M | $137.0M | $77.3M | |||||
| Liabilities | $22.1M | $26.1M | $29.5M | $37.8M | $38.2M | $39.0M | $35.6M | $35.3M | $34.9M | $21.6M | $5.7M | $4.7M | $5.3M | $10.0M | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $6.3M | $1.0M | -$8.0M | -$9.6M | $3.6M | ||||||||||||||
| Assets Current | $5.0M | $11.1M | $17.8M | $32.4M | $32.0M | $41.4M | $63.2M | $76.4M | $89.0M | $100.7M | $98.0M | $109.3M | $132.4M | $69.5M | |||||
| Assets | $10.1M | $16.9M | $24.1M | $43.5M | $43.7M | $53.5M | $70.4M | $83.5M | $96.4M | $108.2M | $104.3M | $115.3M | $137.0M | $77.3M | |||||
| Accounts Payable Current | $2.5M | $1.8M | $1.5M | $1.6M | $506.0K | $806.0K | $1.4M | $1.0M | $1.5M | $1.8M | $1.4M | $1.3M | $1.3M | $1.7M | |||||
| Minority Interest | -$4.1M | -$3.6M | -$2.3M | $2.7M | $2.7M | $7.1M | $17.3M | $24.1M | $30.9M | $44.4M | $50.8M | $57.3M | $80.3M | ||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Long Term Debt Noncurrent | $0.00 | $2.2M | $5.9M | $13.5M | $17.2M | $20.9M | $28.1M | $29.3M | $29.2M | $14.1M | $0.00 | $0.00 | |||||||
| Operating Lease Right Of Use Asset Amortization Expense | $477.0K | $378.0K | $260.0K | $157.0K | $0.00 | ||||||||||||||
| Operating Lease Right Of Use Asset | $4.0M | $4.4M | $4.7M | $5.4M | $5.8M | $6.0M | $959.0K | $1.2M | $1.4M | $1.3M | $999.0K | $1.2M | |||||||
| Operating Lease Liability Noncurrent | $3.0M | $3.2M | $3.4M | $4.0M | $4.4M | $4.7M | $171.0K | $338.0K | $500.0K | $318.0K | $341.0K | $509.0K | |||||||
| Operating Lease Liability Current | $1.0M | $1.2M | $1.3M | $1.4M | $1.4M | $1.2M | $788.0K | $856.0K | $923.0K | $984.0K | $658.0K | $650.0K | |||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $0.00 | $4.7M | $0.00 | $0.00 | |||||||||||||||
| Marketable Securities | $0.00 | $0.00 | $5.7M | $26.1M | $26.4M | $32.7M | $55.6M | $67.1M | $67.8M | $71.0M | |||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $3.0K | $3.0K | $2.0K | $8.0K | -$5.0K | -$11.0K | -$41.0K | -$63.0K | -$10.0K | -$57.0K | |||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $150.0K | $340.0K | $699.0K | $0.00 | |||||||||||||||
| Long Term Debt Current | $13.5M | $15.0M | $15.0M | $14.8M | $12.3M | $8.6M | $1.2M | $0.00 | $3.9M | ||||||||||
| Accrued Liabilities And Other Liabilities | $2.1M | $2.6M | $2.3M | $1.9M | $2.4M | $2.8M | $3.9M | $3.8M | $2.7M | ||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $97.2M | $107.8M | $117.5M | $129.7M | $69.3M | $76.7M | $73.1M | $11.4M | $7.9M | ||||||||||
| Other Operating Activities Cash Flow Statement | $0.00 | $67.0K | |||||||||||||||||
| Other Assets Noncurrent | $245.0K | $293.0K | $246.0K | $246.0K | $246.0K | $246.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Payments To Acquire Property Plant And Equipment | $88.0K | $268.0K | $1.2M | $1.6M | $506.0K | $1.2M |
| Net Cash Provided By Used In Operating Activities | -$18.7M | -$35.5M | -$51.2M | -$46.5M | -$32.2M | -$15.0M |
| Net Cash Provided By Used In Investing Activities | -$7.0M | $19.8M | $29.9M | -$72.4M | -$506.0K | -$1.2M |
| Net Cash Provided By Used In Financing Activities | $40.3M | $13.6M | $233.0K | $29.0M | $77.1M | $72.7M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $192.0K | -$631.0K | -$282.0K | -$505.0K | $2.0M | $9.0K |
| Increase Decrease In Accrued Liabilities | $3.2M | $350.0K | -$540.0K | $605.0K | $739.0K | -$636.0K |
| Increase Decrease In Accounts Payable Trade | -$1.1M | $711.0K | -$595.0K | $163.0K | $543.0K | $933.0K |
| Share Based Compensation | $11.8M | $16.0M | $19.0M | $15.8M | $22.6M | |
| Proceeds From Stock Plans | $12.0K | $15.0K | $40.0K | $46.0K | $0.00 | |
| Increase Decrease In Operating Lease Liability | -$1.9M | -$1.8M | -$1.0M | -$764.0K | $0.00 | |
| Payments To Acquire Marketable Securities | $33.7M | $57.5M | $73.3M | $73.8M | $0.00 | |
| Payments Related To Tax Withholding For Share Based Compensation | $59.0K | $47.0K | $162.0K | $626.0K | $0.00 | |
| Proceeds From Sale And Maturity Of Marketable Securities | $26.8M | $77.6M | $104.4M | $3.0M | $0.00 | |
| Proceeds From Issuance Of Common Stock Under The Employee Stock Purchase Plan | $61.0K | $304.0K | $355.0K | $271.0K | $0.00 | |
| Increase Decrease In Deferred Revenue | $8.5M | $0.00 | $0.00 | -$2.7M | $2.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q3 2024 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Payments To Acquire Property Plant And Equipment | $51.0K | $18.0K | $248.0K | $254.0K | $99.0K | |
| Net Cash Provided By Used In Operating Activities | -$8.1M | -$9.4M | -$12.2M | -$9.4M | -$4.0M | |
| Net Cash Provided By Used In Investing Activities | $18.2M | $10.3M | $4.1M | -$254.0K | -$99.0K | |
| Net Cash Provided By Used In Financing Activities | -$3.7M | $121.0K | $8.0K | $0.00 | $7.8M | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$347.0K | -$499.0K | -$316.0K | -$721.0K | -$27.0K | |
| Increase Decrease In Accrued Liabilities | $170.0K | $884.0K | $323.0K | $653.0K | $821.0K | |
| Increase Decrease In Accounts Payable Trade | $161.0K | $158.0K | $76.0K | $78.0K | $385.0K | |
| Share Based Compensation | $3.9M | $3.9M | $4.4M | $2.9M | $453.0K | |
| Proceeds From Stock Plans | $42.0K | $8.9M | $121.0K | $132.0K | $0.00 | |
| Increase Decrease In Operating Lease Liability | -$478.0K | -$378.0K | -$259.0K | -$157.0K | $0.00 | |
| Payments To Acquire Marketable Securities | $2.7M | $10.0M | $18.6M | $0.00 | ||
| Payments Related To Tax Withholding For Share Based Compensation | $23.0K | $0.00 | $124.0K | $0.00 | ||
| Proceeds From Sale And Maturity Of Marketable Securities | $21.0M | $20.4M | $23.0M | $0.00 | ||
| Proceeds From Issuance Of Common Stock Under The Employee Stock Purchase Plan | ||||||
| Increase Decrease In Deferred Revenue | $0.00 | -$756.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Diluted EPS * | -$0.45 | -$1.05 | -$1.33 | -$1.28 | -$0.43 |
| Earnings Per Share Basic | $-0.45 | $-1.05 | $-1.33 | $-1.28 | $-0.43 |
| Weighted Average Number Of Shares Outstanding Basic | 66.1K | 28.5K | 25.5K | 23.8K | 19.5K |
| Weighted Average Number Of Diluted Shares Outstanding | 66.1K | 28.5K | 25.5K | 23.8K | 19.5K |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.12 | -$0.18 | -$0.22 | -$0.24 | -$0.26 | -$0.29 | -$0.36 | -$0.37 | -$0.33 | $0.33 | $0.31 | $0.29 | -$0.16 | -$0.12 | -$0.06 |
| Earnings Per Share Basic | $-0.12 | $-0.18 | $-0.22 | $-0.24 | $-0.26 | $-0.29 | $-0.36 | $-0.37 | $-0.33 | $0.33 | $0.31 | $0.29 | $-0.16 | ||
| Weighted Average Number Of Shares Outstanding Basic | 46.4M | 36.5M | 33.4M | 28.8M | 26.3M | 26.0M | 25.6M | 25.3M | 25.2M | 24.5M | 24.4M | 21.4M | 19.4M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 46.4M | 36.5M | 33.4M | 28.8M | 26.3M | 26.0M | 25.6M | 25.3M | 25.2M | 24.5M | 24.4M | 21.4M | 19.4M | ||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Authorized | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $11.8M | $16.0M | $19.0M | $15.8M | $17.3M | |
| Interest And Other Income | $827.0K | $1.8M | $3.3M | $1.2M | $89.0K | |
| Prepaid Expense Current | $1.6M | $1.7M | $2.3M | $2.4M | $2.1M | $167.0K |
| Additional Paid In Capital | $165.6M | $104.9M | $85.8M | $75.8M | $55.7M | $0.00 |
| Adjustments To Additional Paid In Capital Other | -$59.0K | $4.0K | -$162.0K | -$626.0K | ||
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $18.0K | $355.0K | $145.0K | ||
| Prepaid Interest | $121.0K | $9.0K | $148.0K | $44.0K | $0.00 | |
| Exchanges Of Paired Interests And Non Corresponding Class A Units | $298.0K | $721.0K | $169.0K | $78.5M | $0.00 | |
| Amortization Of Financing Costs And Discounts | $207.0K | $232.0K | $232.0K | $77.0K | $0.00 | |
| Depreciation And Amortization | $900.0K | $1.0M | $822.0K | $548.0K | $497.0K | |
| Fair Value Adjustment Of Warrants | $0.00 | $371.0K | $63.0K | |||
| Partners Capital | -$113.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.3M | $3.3M | $3.9M | $4.0M | $4.1M | $3.9M | $5.0M | $5.1M | $4.4M | $4.4M | $4.0M | $2.9M | $17.0M | $282.0K | $453.0K | ||||
| Interest And Other Income | $68.0K | $158.0K | $218.0K | $414.0K | $439.0K | $549.0K | $839.0K | $896.0K | $891.0K | $379.0K | $35.0K | $15.0K | $13.0K | $13.0K | |||||
| Prepaid Expense Current | $811.0K | $857.0K | $1.3M | $2.0M | $1.1M | $1.8M | $2.7M | $1.8M | $1.8M | $812.0K | $1.4M | $2.6M | $165.0K | ||||||
| Additional Paid In Capital | $114.4M | $111.3M | $107.1M | $97.1M | $90.0M | $87.8M | $83.4M | $80.7M | $78.0M | $72.4M | $70.0M | $67.9M | $54.5M | ||||||
| Adjustments To Additional Paid In Capital Other | -$7.0K | -$8.0K | -$23.0K | -$1.0K | $14.0K | -$29.0K | -$9.0K | -$124.0K | -$626.0K | ||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $48.0K | $85.0K | $135.0K | $58.0K | ||||||||||||||
| Prepaid Interest | $13.0K | $18.0K | $17.0K | $29.0K | $51.0K | $166.0K | $188.0K | $186.0K | $125.0K | $30.0K | $0.00 | $0.00 | $0.00 | ||||||
| Exchanges Of Paired Interests And Non Corresponding Class A Units | $0.00 | $298.0K | $0.00 | $73.2M | |||||||||||||||
| Amortization Of Financing Costs And Discounts | $58.0K | $58.0K | $58.0K | $0.00 | |||||||||||||||
| Depreciation And Amortization | $251.0K | $248.0K | $188.0K | $111.0K | |||||||||||||||
| Fair Value Adjustment Of Warrants | $0.00 | $0.00 | $85.0K | $70.0K | $216.0K | $0.00 | -$672.0K | ||||||||||||
| Partners Capital | -$123.7M | -$118.5M | -$107.6M | -$104.7M | -$102.0M | -$96.6M |
Most recent annual filing with the SEC: March 26, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.